Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

ZNTL

ZNTL News

Newswire

08:19

Zentalis Pharmaceuticals' Cash Burn Rate and Its Implications for Investors

16:04

Zentalis Pharmaceuticals: Last Hope for Approval of PROC Treatment

12:31

Morgan Stanley maintains Equal-Weight rating on Zentalis with $4 PT, down from $8.

08:21

Zentalis Pharmaceuticals to Present at Upcoming Investor Conferences

15:33

Zentalis Pharmaceuticals shares fall 1.45% intraday after announcing inducement grants to new employees.

View More

About ZNTL

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More